Skip to main content

Table 1 Baseline characteristics of hematologic oncology and subgroup of HCT patients

From: Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration

VariablesAll hematologic oncology patients (n = 401)HCT patients (n = 145)
Age, years, mean (SD)61.6 (15.3)53.1 (14.3)
Male, n (%)254 (63.3)88 (60.7)
Hematologic diagnosis
 Leukemia157 (39.2)82 (56.6)
 Lymphoma131 (32.7)35 (24.1)
 Multiple myeloma60 (14.7)10 (6.9)
 Other53 (13.2)18 (12.4)
Admission source, n (%)
 Home341 (85.0)123 (84.8)
 Acute care facility transfer21 (5.2)11 (7.6)
 Long-term care facility transfer31 (7.7)9 (6.2)
 Other8 (2.0)2 (1.4)
Comorbidities, n (%)
 Congestive heart failure43 (10.7)6 (4.1)
 Arrhythmia66 (16.5)28 (19.3)
 Valvular disease5 (1.2)2 (1.4)
 Peripheral vascular disease2 (0.5)1 (0.7)
 Hypertension80 (20.0)23 (15.9)
 Chronic obstructive pulmonary disease30 (7.5)8 (5.5)
 Diabetes mellitus129 (32.2)45 (31.0)
 Renal failure26 (6.5)4 (2.8)
 Liver disease17 (4.2)10 (6.9)
 Metastatic cancer15 (3.7)6 (4.1)
Elixhauser comorbidity score, mean (SD)9.6 (8.2)7.7 (6.6)
Emergency department visits in past year, median (IQR)1 (0–2)0 (0–1)
Hospital admissions in the past year, median (IQR)1 (0–2)1 (0–3)
ICU admissions in the past year, median (IQR)0 (0–0)0 (0–0)
Limits of care, n (%)
 Full care300 (74.8)126 (86.9)
 ICU-level care, no CPR22 (5.5)4 (2.8)
 Do not resuscitate56 (14.0)6 (4.1)
 Other/unknown23 (5.7)9 (6.2)
  1. Abbreviations: RRS rapid response system, SD standard deviation, IQR interquartile range, ICU intensive care unit, CPR cardiopulmonary resuscitation